Losartan for Patients With COVID-19 Not Requiring Hospitalization
Status:
Completed
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, double-blinded study of COVID-19 infected patients randomized 1:1 to
daily losartan or placebo for 10 days or treatment failure (hospital admission).